article thumbnail

Cannabinoids for Tinnitus?

Project CBD

That’s what appeared to happen in rats injected with the synthetic CB1 agonists WIN55,212‐2 and CP55,940 in a 2010 study 4 and THC and CBD in a 1:1 ratio in a 2011 follow-up study. 268,1-2 (2010): 145-50. While the collective evidence to date is mixed and inconclusive, it’s also incomplete. 5,6 1147-1155. Hearing research vol.

article thumbnail

Press Release: Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2

Cannabis Law Report

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Husch Blackwell Launches Psychedelics and Emerging Therapies Practice Group

Cannabis Law Report

Food and Drug Administration (FDA) guidance on clinical trials, Drug Enforcement Agency (DEA) licensing, material transfer agreements and cooperative research and development agreements (CRDA). Since 2010, Steve’s major focus has been on the burgeoning cannabis industry, where he guides clients through the tangle of.

Therapy 52
article thumbnail

Transplant Denied To Med Marijuana Patient With Liver Cancer

Otherside Farms

Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list. .

article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

raced as a professional triathlete from 1998-2010. She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). Our results need to be replicated in larger studies and clinical trials. Study co-author Joanna Zeiger, MS, Ph.D.

article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

raced as a professional triathlete from 1998-2010. She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). Our results need to be replicated in larger studies and clinical trials. Study co-author Joanna Zeiger, MS, Ph.D.

article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

NYSE: AMAM), a position he previously held from 2010 through 2015. I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S.